Actively Recruiting
CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure
Led by BONESUPPORT AB · Updated on 2026-05-04
128
Participants Needed
1
Research Sites
382 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is a prospective cohort study of subjects where CERAMENT G was used as part of the surgical treatment of osteomyelitis in a single stage procedure.
CONDITIONS
Official Title
CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients receiving CERAMENT G after surgical removal of osteomyelitis with Cierny-Mader grades III or IV
- Need for management of bone defects after infection removal
- Symptoms lasting at least six months with clinical and radiological signs
- Presence of at least one: sinus, abscess or pus during surgery, positive histology, or two or more matching microbiological cultures
- Inclusion of infected non-unions only if bone loss is less than 1 cm after surgery
You will not qualify if you...
- Skeletal immaturity shown by incomplete bone growth on prior X-rays
- Unable or unwilling to give informed consent
- Known allergy to gentamicin or calcium sulfate
- Treatment with multiple types of antibiotic-eluting bone grafts
- Segmental bone defect larger than 1 cm
- Infection located in the spine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bone Infection Unit, Nuffield Orthopaedic Centtre, Oxford University Hospitals, MHS
Oxford, United Kingdom, OX37HE
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here